Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECHOGUIDE: Meniscal Wall vs Intra-articular Infiltration for Meniscal Injuries
NCT05235854Phase 1Completed
- Sponsor
- CHU Nîmes
- Start
- May 2022
- Primary completion
- May 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of betamethasone in meniscal tear (2 arms), sponsored by CHU Nîmes. Primary endpoint: Lysholm algo-functional score. Started May 2022; status: completed.
02
Drugs
betamethasone
03
Conditions
meniscal tear
Beyond the preview
Go deeper on NCT05235854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05235854.